torsdag den 6. april 2017

Are Tesla shares shockingly overpriced?

Follow this link if this email is not displaying correctly
DAILY BULLETIN
Thursday 6 April 2017
Tesla's promises are too expensive
by Filipe R Costa | Equities | 5 mins. to read
Tesla
Although many investors wouldn't agree with me, I believe that one of the main aberrations in the U.S. stock market is the fact that Tesla Inc (NASDAQ:TSLA) is worth the same as General Motors Company (NYSE:GM), despite the huge differences between them in terms of revenues, profits, margins, market share, operational aspects and financial strength. Tesla is no more than an expensive punt on promising future prospects, while General Motors is a cheap bet on a profitable reality.

Trading on less than 6x earnings, General Motors seems like a cheap stock to hold. The same can't be said about Tesla's stock, which trades on more than 115x its 2018 projected earnings. At such high prices Tesla seems like an epic short for all investors that have their feet on the ground. Luck has been tilted in favour of Elon Musk, who seems to be supported by governments and investors without ever turning a profit.

 
Click here to read the full story
LATEST STORIES FROM OUR BLOG

VisageAll presentations from Master Investor 2017 are now available to watch on demand! 

If you'd like to catch up with any of the talks from last month's event, they've all been uploaded to our site and can be viewed at your convenience.
 
Click here to see the videos

ChartingCharting a path to success

by David Jones Trading 8 mins. to read
One of the many common criticisms that could be aimed at a charting approach to the market (and there are quite a few): If it works, why aren't all chartists fabulously rich?
 
Click here to read the full story

Graphene Nanochem: Wedge break could lead back to 18p

by Zak Mir | Trading | 1 mins. to read
It would appear that courtesy of the latest claims regarding wonder substance Graphene, the phrase "Water, water everywhere and not a drop to drink" could be outmoded.
 
Click here to read the full story

SpaceX goes medical

by Victor Hill | Equities | 9 mins. to read
Space exploration and biotech team up in zero gravity I recently argued that SpaceX is much more than a billionaire's ego trip – even if its revenue model is sometimes obscured by grandiose schemes like taking rich tourists to the moon.
 
Click here to read the full story

Why Centrica's strategy lacks investment appeal

by Robert Stephens | Equities | 5 mins. to read
A change in strategy can reignite a company's profit growth. Or, it can lead to large opportunity costs. In my opinion, Centrica's decision to refocus on its customer-facing supply business at the expense of its Oil & Gas operations falls into the latter category.
 
Click here to read the full story
QUOTE OF THE DAY

"People think computers will keep them from making mistakes. They're wrong. With computers you make mistakes faster."
                                                Adam Osborne
MASTER INVESTOR SHOW VIDEO EXCLUSIVE
Empowering Investors
LATEST EDITION OUT NOW

Fidelity's Tom Stevenson - Keeping the faith with markets
  • Money for nothing - Alan Steel explains the power of pensions
  • Oil majors go green - How the oil titans are adapting in the age of renewables
  • Making Mexico great again - Mexican stocks look good value after Trump's tirade
  • How to avoid yield traps - We explain how to navigate this common pitfall
Click here to download as PDF
 
Click here to read online
 
Master Investor Magazine 19
Master Investor Ltd.
Suite 88, 22 Notting Hill Gate
London, W11 3JE

T: +44 7515 542707
E: swen@masterinvestor.co.uk
Share the newsletter:
Follow us:
Copyright © 2017 Master Investor Ltd, All rights reserved.
Master Investor is a trading name of Master Investor Ltd.

Material contained within Master Investor Magazine and its website is for general information purposes only and is not intended to be relied upon by individual readers in making (or refraining from making) any specific investment decisions. Master Investor Ltd. does not accept any liability for any losses suffered by any user as a result or any such descision.

If a Daily Bulletin is too frequent, why not opt in to our once weekly mailing list
for a round up of the week's news.

Want to change how you receive these emails?
Why did I get this | Unsubscribe from this list | Update subscription preferences

Ingen kommentarer:

Send en kommentar